Acta Oncologica · 1989 · 14 citations · 11 references
MedicineOncologyPediatricsChemotherapyMedical OncologyPediatric OncologyCancer Survival AnalysisMalignant NeoplasmsPediatric ChemotherapyPediatric SarcomasPediatric TumorsSoft Tissue SarcomasClinical RemissionPositive Predictive ValueRhabdomyosarcoma TreatmentSoft Tissue Sarcoma Treatment
The relation between the initial tumour regression produced by chemotherapy and the later event-free survival was studied in a prospective multicentre study on soft-tissue sarcomas in children. The event-free survival rate in patients with complete remission after seven weeks of chemotherapy was 95%; in patients with incomplete tumour reduction of greater than 2/3, 61%; and in patients with tumour reduction of less than 2/3 but greater than 1/3, 31%. Patients with partial remission at week 7, who achieved complete remission by week 16 after additional chemotherapy had an event-free survival rate of 64%. A multivariate analysis suggested that the response per unit of time was an important prognostic factor.
11
Gene amplification, drug resistance, and cancer.
Robert Schimke · PubMed · 1984 · 284 citations
Prognosis in childhood rhabdomyosarcoma
Wataru W. Sutow, M. P. Sullivan, Hubert L. Ried et al. · Cancer · 1970 · 207 citations · Full text
Medicine, Oncology, Pediatrics +14
Multidisciplinary treatment of embryonal rhabdomyosarcoma in children
Fereshteh Ghavimi, Philip R. Exelby, Giulio J. D’Angio et al. · Cancer · 1975 · 168 citations
Intensive chemotherapy as primary treatment for rhabdomyosarcoma of the pelvis
Georges E. Rivard, Robert E. Hittle, Ruprecht Nitschke et al. · Cancer · 1975 · 73 citations · Full text